Facebook Instagram linkedin YouTube
Sentence of the Day


Research focus
Thrust Areas
1. Formulation and characterization of drug delivery systems such as
•  Microspheres
•  Transdermal patches
•  In situ ocular gels
•  Nanoparticles
•  Immediate release tablets
•  Herbal extracts
2. Bioavailability and bioequivalence studies

Funded projects:

S.No Title of the Project Funding Agency Year Amount (Rs.)
1. SABA MAANVIZHI Effort grant Electro lab 2017 10,00000/-
2. National Post doctoral fellowship SHANMUGANATHAN S DST - SERB 2016 19,20,000/-
3. Stimuli sensitive hydrogels in ocular drug delivery system - S NAGALAKSHMI DRDO- LSRB 2014 21,26,780/-
4. Formulation and evaluation of nanoparticles loaded with antimicrobial drug using different natural polymers - S SHANMUGANATHAN SERC division (Life sciences) 2014 10,15,000/-

Fulfilled as per the apex body requirements. To list the some of the equipments (above 2 Lakh)
• Model machine room
• Rotary tablet punching Machine ( 8 station)
• Brook field viscometer
• Homogenizer
• Probe Sonicator

Collaborating institutions/ industry
Himalaya Drug Company, Bengaluru
BIOCON, Bengaluru
Central Leather Research Institute, Chennai
Mylan Laboratories Ltd. Hyderabad
Hospira Health Care India Pvt Ltd, Chennai
Orchid Chemicals and Pharmaceuticals, Chennai
Hetero Drugs, Hyderabad
Vergo Pharma Research, Goa
Fourrts (India) Laboratories Pvt. Limited, Chennai
Softgels Pvt. Ltd., Chennai
Par Formulations, Chennai
Cipla, Mumbai

Patent filed by Faculty
• “Novel synergistic polyherbal cleansing composition and products thereof” with patent application number: 5954/CHE/2015 by Mrs. X. Fatima Grace and Shanmuganathan S.
• “A novel biocompatible sustained release nanoparticles pharmaceutical formulation and method of preparation” with patent application number: 4313/CHE/2015 by  Shanmuganathan S
• “Sustained release nano particle pharmaceutical formulation utilising Azadirachta indica fruit mucilage” with patent application number: 3634/CHE/2015  by  Shanmuganathan S
• “Use of natural bio-enhancer to improve safety and efficacy of conventional anti-arthritic drug” with patent application number: 1547/CHE/2013 by Mrs. X. Fatima Grace.

M. Pharm /Ph.D:
Ph. D Guided: 1 completed
M.Pharm Guided: 75 completed


S.No Fellowship Funding Agency Research scholar
1. JRF DST-SERB Ms. B. Harika
2. JRF DRDO - LSRB Mr. B. Anbarasan
3. PDF DST-SERB Mr. R. Satiesh Kumar